Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | REGN | GSK | ||
| Company | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | ||
| Open | 44.68 | 881.72 | 40.95 | ||
| High | 45.37 | 887.48 | 41.31 | ||
| Low | 44.34 | 875.22 | 40.87 | ||
| Last | 44.85 | 883.20 | 41.11 | ||
| Change | +0.15 | -7.48 | +0.20 | ||
| % Change | +0.34% | -0.84% | +0.49% | ||
| Volume | 21,281,900 | 505,600 | 2,730,400 | ||
| 20-Day Average Volume | 13,205,370 | 457,100 | 3,041,155 | ||
| Previous Close | 44.70 | 890.68 | 40.91 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 49.47 | 918.54 | 40.77 | ||
| 20-Day Raw Stochastic | 5.16% | 8.40% | 52.62% | ||
| 20-Day Relative Strength | 29.15% | 33.09% | 49.79% | ||
| Weighted Alpha | -34.43 | +9.82 | +16.25 | ||
| Today's Opinion | 88% Sell | 8% Sell | 56% Buy | ||
| Previous Opinion | 88% Sell | 8% Buy | 56% Buy | ||
| Last Month's Opinion | 8% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.34% since 04/19/24 | -1.52% since 04/19/24 | +3.42% since 04/19/24 | ||
| Low | 44.34 on 04/26/24 | 875.22 on 04/26/24 | 39.96 on 04/22/24 | ||
| High | 49.56 on 04/22/24 | 915.70 on 04/24/24 | 41.31 on 04/26/24 | ||
| 1-Month | |||||
| %Chg | -14.65% since 03/26/24 | -8.34% since 03/26/24 | -3.93% since 03/26/24 | ||
| Low | 44.34 on 04/26/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 | ||
| High | 54.47 on 03/28/24 | 976.75 on 03/27/24 | 43.22 on 03/28/24 | ||
| 3-Month | |||||
| %Chg | -9.76% since 01/26/24 | -6.05% since 01/26/24 | +5.22% since 01/26/24 | ||
| Low | 44.34 on 04/26/24 | 875.22 on 04/26/24 | 38.86 on 01/29/24 | ||
| High | 55.03 on 03/13/24 | 998.33 on 02/28/24 | 43.84 on 03/07/24 | ||
| 6-Month | |||||
| %Chg | -15.33% since 10/26/23 | +11.51% since 10/26/23 | +15.22% since 10/26/23 | ||
| Low | 44.34 on 04/26/24 | 769.19 on 10/27/23 | 33.67 on 11/02/23 | ||
| High | 55.03 on 03/13/24 | 998.33 on 02/28/24 | 43.84 on 03/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 90,596,128 | 97,762,816 | 84,783,520 | ||
| Shares Outstanding, K | 2,026,759 | 109,762 | 2,072,440 | ||
| Annual Sales | 45,006,000,000 | 13,117,200,000 | 37,725,000,000 | ||
| Annual Net Income | 8,025,000,000 | 3,953,600,000 | 6,129,940,000 | ||
| Last Quarter Sales | 11,477,000,000 | 3,434,300,000 | 9,980,060,000 | ||
| Last Quarter Net Income | 1,762,000,000 | 1,159,600,000 | 433,200,000 | ||
| 60-Month Beta | 0.39 | 0.11 | 0.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -4.40 on 04/25/24 | 11.86 on 02/02/24 | 0.72 on 01/31/24 | ||
| Latest Earnings Date | 04/25/24 | 05/02/24 | 05/01/24 | ||
| Most Recent Dividend | 0.600 on 04/04/24 | N/A | 0.397 on 02/22/24 | ||
| Next Ex-Dividends Date | 04/04/24 | N/A | 02/22/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 6.51 | 24.12 | 10.61 | ||